Literature DB >> 20536568

Heterologous immunity between viruses.

Raymond M Welsh1, Jenny W Che, Michael A Brehm, Liisa K Selin.   

Abstract

Immune memory responses to previously encountered pathogens can sometimes alter the immune response to and the course of infection of an unrelated pathogen by a process known as heterologous immunity. This response can lead to enhanced or diminished protective immunity and altered immunopathology. Here, we discuss the nature of T-cell cross-reactivity and describe matrices of epitopes from different viruses eliciting cross-reactive CD8(+) T-cell responses. We examine the parameters of heterologous immunity mediated by these cross-reactive T cells during viral infections in mice and humans. We show that heterologous immunity can disrupt T-cell memory pools, alter the complexity of the T-cell repertoire, change patterns of T-cell immunodominance, lead to the selection of viral epitope-escape variants, alter the pathogenesis of viral infections, and, by virtue of the private specificity of T-cell repertoires within individuals, contribute to dramatic variations in viral disease. We propose that heterologous immunity is an important factor in resistance to and variations of human viral infections and that issues of heterologous immunity should be considered in the design of vaccines.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20536568      PMCID: PMC2917921          DOI: 10.1111/j.0105-2896.2010.00897.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  162 in total

1.  Rapid production of TNF-alpha following TCR engagement of naive CD8 T cells.

Authors:  Michael A Brehm; Keith A Daniels; Raymond M Welsh
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

Review 2.  Polyspecificity of T cell and B cell receptor recognition.

Authors:  Kai W Wucherpfennig; Paul M Allen; Franco Celada; Irun R Cohen; Rob De Boer; K Christopher Garcia; Byron Goldstein; Ralph Greenspan; David Hafler; Philip Hodgkin; Erik S Huseby; David C Krakauer; David Nemazee; Alan S Perelson; Clemencia Pinilla; Roland K Strong; Eli E Sercarz
Journal:  Semin Immunol       Date:  2007-03-29       Impact factor: 11.130

3.  An analysis of cytomegalovirus infection and HLA antigen matching on the outcome of renal transplantation.

Authors:  A G May; R F Betts; R B Freeman; C H Andrus
Journal:  Ann Surg       Date:  1978-02       Impact factor: 12.969

4.  Virus-induced polyclonal cytotoxic T lymphocyte stimulation.

Authors:  H Y Yang; P L Dundon; S R Nahill; R M Welsh
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

Review 5.  Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree.

Authors:  T Oettinger; M Jørgensen; A Ladefoged; K Hasløv; P Andersen
Journal:  Tuber Lung Dis       Date:  1999

Review 6.  No one is naive: the significance of heterologous T-cell immunity.

Authors:  Raymond M Welsh; Liisa K Selin
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

7.  Viral infection and renal transplant rejection.

Authors:  J D Briggs; M C Timbury; A M Paton; P R Bell
Journal:  Br Med J       Date:  1972-12-02

8.  Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance.

Authors:  Maya F Kotturi; Iain Scott; Tom Wolfe; Bjoern Peters; John Sidney; Hilde Cheroutre; Matthias G von Herrath; Michael J Buchmeier; Howard Grey; Alessandro Sette
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

9.  Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease.

Authors:  C F Evans; M S Horwitz; M V Hobbs; M B Oldstone
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

10.  Cross-reactivity between HLA-A2-restricted FLU-M1:58-66 and HIV p17 GAG:77-85 epitopes in HIV-infected and uninfected individuals.

Authors:  Paula M Acierno; Danforth A Newton; Edwin A Brown; Lou Anne Maes; John E Baatz; Sebastiano Gattoni-Celli
Journal:  J Transl Med       Date:  2003-08-14       Impact factor: 5.531

View more
  142 in total

Review 1.  Immune modulation during latent herpesvirus infection.

Authors:  Douglas W White; R Suzanne Beard; Erik S Barton
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

Review 2.  Computer simulations of heterologous immunity: highlights of an interdisciplinary cooperation.

Authors:  Claudia Calcagno; Roberto Puzone; Yanthe E Pearson; Yiming Cheng; Dario Ghersi; Liisa K Selin; Raymond M Welsh; Franco Celada
Journal:  Autoimmunity       Date:  2011-01-27       Impact factor: 2.815

3.  The polyclonal CD8 T cell response to influenza M158-66 generates a fully connected network of cross-reactive clonotypes to structurally related peptides: a paradigm for memory repertoire coverage of novel epitopes or escape mutants.

Authors:  Galina V Petrova; Elena N Naumova; Jack Gorski
Journal:  J Immunol       Date:  2011-04-25       Impact factor: 5.422

4.  Inflammatory IL-15 is required for optimal memory T cell responses.

Authors:  Martin J Richer; Lecia L Pewe; Lisa S Hancox; Stacey M Hartwig; Steven M Varga; John T Harty
Journal:  J Clin Invest       Date:  2015-08-04       Impact factor: 14.808

5.  Cytomegalovirus infection enhances the immune response to influenza.

Authors:  David Furman; Vladimir Jojic; Shalini Sharma; Shai S Shen-Orr; Cesar J L Angel; Suna Onengut-Gumuscu; Brian A Kidd; Holden T Maecker; Patrick Concannon; Cornelia L Dekker; Paul G Thomas; Mark M Davis
Journal:  Sci Transl Med       Date:  2015-04-01       Impact factor: 17.956

Review 6.  Some unmet challenges in the immunology of viral infections.

Authors:  Barry T Rouse; Aron E Lukacher
Journal:  Discov Med       Date:  2010-10       Impact factor: 2.970

7.  PC61 (anti-CD25) treatment inhibits influenza A virus-expanded regulatory T cells and severe lung pathology during a subsequent heterologous lymphocytic choriomeningitis virus infection.

Authors:  Anke R M Kraft; Myriam F Wlodarczyk; Laurie L Kenney; Liisa K Selin
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

8.  Resistance to two heterologous neurotropic oncolytic viruses, Semliki Forest virus and vaccinia virus, in experimental glioma.

Authors:  Markus J V Vähä-Koskela; Fabrice Le Boeuf; Chantal Lemay; Naomi De Silva; Jean-Simon Diallo; Julie Cox; Michelle Becker; Youngmin Choi; Abhirami Ananth; Clara Sellers; Sophie Breton; Dominic Roy; Theresa Falls; Jan Brun; Akseli Hemminki; Ari Hinkkanen; John C Bell
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

Review 9.  Cytomegalovirus and HIV: A Dangerous Pas de Deux.

Authors:  Sara Gianella; Scott Letendre
Journal:  J Infect Dis       Date:  2016-10-01       Impact factor: 5.226

10.  MHC basis of T cell-dependent heterologous immunity to arenaviruses.

Authors:  Keith A Daniels; Steven D Hatfield; Raymond M Welsh; Michael A Brehm
Journal:  Virology       Date:  2014-08-03       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.